Skip to main content

People In The News: Dec 16, 2011

NEW YORK (GenomeWeb News) – Illumina has appointed Laura Lauman to be VP of marketing. In leading global marketing efforts, she will assume the responsibilities of Omead Ostadan, who has taken a new executive leadership role with the company.

Lauman formerly was president of AB Sciex and she spent 15 years at Life Technologies/Applied Biosystems, where she was division president and GM of the Proteomics and Small Molecule Division. She also held commercial and business leadership roles at PerkinElmer and Waters.


Roche this week said that Dan Zabrowski will leave his position as head of Roche Partnering to become head of Roche Applied Science in the company's Diagnostics Division. The company said that Sophie Kornowski-Bonnet, who currently is GM of Roche Pharma in France, will succeed Zabrowski.


Metabolon has named Eric Button senior VP of diagnostics. Button has been president of GlycoMark, he was president and CEO of Amplistar, and he was president and CEO of Innovex Diagnostics.


Agilent Technologies has appointed Gooi Soon Chai to be senior VP of order fulfillment and supply chain, wherein he will run a new, centralized organization aimed at leveraging the company's manufacturing and procurement capabilities across its three business groups. Chai has been with the company since 1985, and he established Agilent's instruments business unit in Asia and coordinated the global supply chain for its electronic measurement business.


Interleukin Genetics has appointed Lynn Doucette-Stamm to vice president of development, a newly created position. In the role, she will supervise the company's clinical studies and development of genetic tests.

Most recently, Doucette-Stamm served as vice president of business development at Agencourt Bioscience. Previously she served as director of genomics and vice president and general manager of the Genome Vision Services Unit at Genome Therapeutics. In that position, she was responsible for managing teams working on the Human Genome Project as well as commercial sequencing programs. She also established the company's genomics business unit.


Marjorie Tingle has left her position as director of the Shared Instrumentation Grant program and the High-End Instrumentation grant program at the National Center for Research Resources. Abraham Levy is acting program director. Tingle has served in the National Institutes of Health's Division of Research Resources and then the NCRR since 1975, developing several programs including the SIG program, which she directed since its inception in 1982.


DVS Sciences has appointed Joseph Victor president and CEO. He will assume the role from DVS co-founder Scott Tanner, who will become the company's chief technology officer and general manager of its Canadian operations. Previously, Victor was president and CEO of Applied Precision, which was recently acquired by GE Healthcare.


Genetic Technologies said this week that it has appointed Mel Bridges to be company chairman and a non-executive director, and that Sid Hack has resigned from his positions as chairman and director. Bridges co-founded Panbio and ImpediMed, and he has served in directorial posts at Benitec and Campbell Brothers and as chairman of Peptech and Alchemia.


National Cheng Kung University in southern Taiwan has appointed Takashi Gojobori to lead its genomics research and teaching program. Gojobori, known for research involving molecular evolution and comparative genomics, currently is vice-director of the National Institute of Genetics and professor at the Center for Information Biology and DNA Data Bank of Japan.


GeneForge said this week that company Founder Bruce Erickson plans to retire at the end of this year. Earlier this year, Erickson sold the company to Mike Bailey.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.